Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Molding as Innovative Technology for Personalized Tablet Production

Author(s):  Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A

Issue:  Mar/Apr 2022 - Volume 26, Number 2
View All Articles in Issue

Page(s):  163-174

Molding as Innovative Technology for Personalized Tablet Production Page 1
Molding as Innovative Technology for Personalized Tablet Production Page 2
Molding as Innovative Technology for Personalized Tablet Production Page 3
Molding as Innovative Technology for Personalized Tablet Production Page 4
Molding as Innovative Technology for Personalized Tablet Production Page 5
Molding as Innovative Technology for Personalized Tablet Production Page 6
Molding as Innovative Technology for Personalized Tablet Production Page 7
Molding as Innovative Technology for Personalized Tablet Production Page 8
Molding as Innovative Technology for Personalized Tablet Production Page 9
Molding as Innovative Technology for Personalized Tablet Production Page 10
Molding as Innovative Technology for Personalized Tablet Production Page 11
Molding as Innovative Technology for Personalized Tablet Production Page 12

Download in electronic PDF format for $75

Abstract:  The future of dosage form design is expected to move towards the production of personalized dosage forms tailored to each patient. The 3D printer was introduced to solve that problem but is not easy to use in a pharmacy. Herein, a new 3D mold technology is adopted for tablet manufacturing. Preparation of amlodipine tablets was used as a Biopharmaceutics Classification System Class 1 drug model to study this technology. Different concentrations of either starch or Avicel-based formulations and different concentrations of hydroxypropyl methylcellulose as a binder for mass formation were used. The mass formed for each formula was cast into the mold for tablet preparation. Different non-pharmacopeial and pharmacopeial quality-control tests of the prepared tablets by using the 3D mold were compared to a marketed tablet product of amlodipine. 3D-molded tablets showed compliance properties with the tablet pharmacopeial quality standard. Studying the equivalence of the 3D mold tablets to the brand marketed product under biowaiver conditions was carried out. The difference and similarity factors studies of molded tablets prepared using starch or Avicel as a filler and 2.5% of hydroxypropyl methylcellulose showed acceptable characters to the drug brand name. It is predicted that by using this simple technique, it would be possible to produce tablets with designed disintegration and release profiles, which could potentially allow the tailoring of the drug release and hence personalize the medicine for each patient. 

Related Keywords: personalized dosage forms, 3-dimensional printing, 3D printing, 3D molding, 3D mold casting, amlodipine, hypertension, high blood pressure, angina, chest pain, coronary artery disease, disintegration time, drug release, personalized medicine, tablet splitting, excipients, content uniformity, tablet hardness, tablet friability, dissolution profile

Related Categories: EXCIPIENTS, PEER-REVIEWED, TECHNOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y
, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Mar/Apr 2022
Pg. 163-174

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
May/Jun 2017
Pg. 215-220

A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties
Mady Omar
May/Jun 2022
Pg. 195-200

Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
Mar/Apr 2017
Pg. 127-130

Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
Jul/Aug 2017
Pg. 293-298

Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate
Ruslan Mohamad Fariz Haiqal
, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022
Pg. 155-162

Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds
Alexander Kenneth S
, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
Nov/Dec 2013
Pg. 512-514

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
Jan/Feb 2023
Pg. 30-37

Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!
Blankenship Cynthia
Nov/Dec 2017
Pg. 468

Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek
, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Mar/Apr 2018
Pg. 108-121

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance
Pellagatti Tommaso
, Ternelli Marco, Frascio Davide, Bettini Ruggero
May/Jun 2017
Pg. 247-250

Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Rodriguez Franklin
, Carvalho Maria, Banov Fabiana
Nov/Dec 2023
Pg. 468-473

Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Harrington Catherine A
, Cauffield Jacintha
Mar/Apr 2005
Pg. 117-119

Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Wung Deanna
Jan/Feb 2013
Pg. 24-27

Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Shawaqfeh Mohammad S
, Harrington Catherine
Jan/Feb 2018
Pg. 19-24

Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 142

Return to Top